Fundraising Fox株式会社PURMX THERAPEUTICS
Hiroshima, JP · 4 known investors
Find your way into 株式会社PURMX THERAPEUTICS
Sign up to see every warm intro you have to 株式会社PURMX THERAPEUTICS
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 株式会社PURMX THERAPEUTICS team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
PURMX Therapeutics develops nucleic acid medicines as anti-cancer drugs based on microRNA research and the concept of an "ageing switch" to induce ageing in cancer cells. The Japanese pharmaceutical venture handles drug development functions including non-clinical research, clinical development, CMC, and regulatory affairs.
Founders & leadership
Investors · 4
Related companies · 1
Companies working in the same space as 株式会社PURMX THERAPEUTICS.
Frequently asked questions
- What does 株式会社PURMX THERAPEUTICS do?
- PURMX Therapeutics develops nucleic acid medicines as anti-cancer drugs based on microRNA research and the concept of an "ageing switch" to induce ageing in cancer cells. The Japanese pharmaceutical venture handles drug development functions including non-clinical research, clinical development, CMC, and regulatory affairs.
- Who founded 株式会社PURMX THERAPEUTICS?
- 株式会社PURMX THERAPEUTICS was founded by Hidetoshi Tahara.
- Who are 株式会社PURMX THERAPEUTICS's investors?
- 株式会社PURMX THERAPEUTICS's investors include Hiroshima Venture Capital Co. Ltd., Keio Innovation Initiative, OSAKA University Venture Capital, UTEC.
- Where is 株式会社PURMX THERAPEUTICS headquartered?
- 株式会社PURMX THERAPEUTICS is headquartered in Hiroshima, JP.